# CCIT

academic TIL programs at cancer institutes.

Source: https://en.bioecon.ru/companies/ccit/
Updated: 2026-06-24

- Country: Denmark

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Affiliation | Herlev Hospital, Department of Oncology, Copenhagen University Hospital | https://www.dccc.dk/english/national-research-centres/national-center-for-cancer-immune-therapy-ccit-dk/ |
| Research focus | cancer immunology and immunotherapy, focusing on experimental and clinical research, including TIL therapy and tumor microenvironment modulation | https://phd-ccr.ku.dk/board/, https://research.regionh.dk/en/organisations/center-for-cancer-immune-therapy-ccit-department-of-oncology-cope/, https://www.dccc.dk/english/national-research-centres/national-center-for-cancer-immune-therapy-ccit-dk/ |
| Facility | GMP certified laboratory for the preparation of therapeutic immunological cellular products | https://www.dccc.dk/english/national-research-centres/national-center-for-cancer-immune-therapy-ccit-dk/ |
| Headcount | Approximately 56 to 70 employees | https://www.dccc.dk/english/national-research-centres/national-center-for-cancer-immune-therapy-ccit-dk/ |
| Principal staff | Inge Marie Svane, Per Thor Straten, and Mads Hald Andersen (Directors/Professors); Özcan Met (Head, Cell Therapy Unit) | https://phd-ccr.ku.dk/board/, https://www.dccc.dk/english/national-research-centres/national-center-for-cancer-immune-therapy-ccit-dk/ |

Independent sources: dccc.dk, phd-ccr.ku.dk, research.regionh.dk

## Technologies

- [TIL therapy (tumor-infiltrating lymphocytes)](https://en.bioecon.ru/technology/til-therapy/)